140 related articles for article (PubMed ID: 17028634)
1. [Echinacea spp. (coneflower) and upper respiratory tract infections].
Raknes G; Småbrekke L
Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2526-7. PubMed ID: 17028634
[No Abstract] [Full Text] [Related]
2. [New knowledge regarding the effect and effectiveness of Echinacea purpurea extracts].
Bauer R
Wien Med Wochenschr; 2002; 152(15-16):407-11. PubMed ID: 12244888
[TBL] [Abstract][Full Text] [Related]
3. The effect of Echinacea on upper respiratory infection symptom severity and quality of life.
Gillespie EL; Coleman CI
Conn Med; 2006 Feb; 70(2):93-7. PubMed ID: 16768061
[TBL] [Abstract][Full Text] [Related]
4. [Purple coneflower as antiviral agent].
Schlenger R
MMW Fortschr Med; 2016 Feb; 158(2):16, 18. PubMed ID: 26961020
[No Abstract] [Full Text] [Related]
5. Echinacea trial.
Blumenthal M
Altern Ther Health Med; 2004; 10(2):12, 14. PubMed ID: 15055087
[No Abstract] [Full Text] [Related]
6. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Gibbons S; Phillipson JD
J Pharm Pharmacol; 2005 Aug; 57(8):929-54. PubMed ID: 16102249
[TBL] [Abstract][Full Text] [Related]
7. Herbal extracts used for upper respiratory tract infections: are there clinically relevant interactions with the cytochrome P450 enzyme system?
Heinrich M; Modarai M; Kortenkamp A
Planta Med; 2008 May; 74(6):657-60. PubMed ID: 18584812
[TBL] [Abstract][Full Text] [Related]
8. Echinacea fails to show efficacy in treating colds in a pediatric population.
Le Tourneau M
Altern Ther Health Med; 2004; 10(1):16. PubMed ID: 14727495
[No Abstract] [Full Text] [Related]
9. Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis.
David S; Cunningham R
Complement Ther Med; 2019 Jun; 44():18-26. PubMed ID: 31126553
[TBL] [Abstract][Full Text] [Related]
10. [Tolerability and efficacy of a herbal combination preparation in children and adolescents with recurrent infections of the upper respiratory tract].
Berger T
MMW Fortschr Med; 2008 Jun; 150 Suppl 2():85-90. PubMed ID: 18712128
[No Abstract] [Full Text] [Related]
11. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
Chicca A; Raduner S; Pellati F; Strompen T; Altmann KH; Schoop R; Gertsch J
Int Immunopharmacol; 2009 Jul; 9(7-8):850-8. PubMed ID: 19303464
[TBL] [Abstract][Full Text] [Related]
12. Echinacea purpurea.
J Soc Integr Oncol; 2007; 5(4):167-8. PubMed ID: 19087761
[No Abstract] [Full Text] [Related]
13. Echinacea for prevention and treatment of upper respiratory infections.
Med Lett Drugs Ther; 2002 Apr; 44(1127):29-30. PubMed ID: 11941266
[No Abstract] [Full Text] [Related]
14. Echinacea for the prevention of upper respiratory tract infections.
Gunning K; Steele P
J Fam Pract; 1999 Feb; 48(2):93. PubMed ID: 10037535
[No Abstract] [Full Text] [Related]
15. Echinacea.
Barnes J
J Prim Health Care; 2009 Jun; 1(2):146-7. PubMed ID: 20690367
[No Abstract] [Full Text] [Related]
16. Echinacea powder: treatment for canine chronic and seasonal upper respiratory tract infections.
Reichling J; Fitzi J; Fürst-Jucker J; Bucher S; Saller R
Schweiz Arch Tierheilkd; 2003 May; 145(5):223-31. PubMed ID: 12784483
[TBL] [Abstract][Full Text] [Related]
17. [Plantain (Plantago lanceolata L.): anti-inflammatory action in upper respiratory tract infections].
Wegener T; Kraft K
Wien Med Wochenschr; 1999; 149(8-10):211-6. PubMed ID: 10483683
[TBL] [Abstract][Full Text] [Related]
18. Echinacea for upper respiratory infections.
Lord RW
J Fam Pract; 1999 Dec; 48(12):939-40. PubMed ID: 10628570
[No Abstract] [Full Text] [Related]
19. Use of plant extracts as an efficient alternative therapy of respiratory tract infections.
Šmejkal K; Rjašková V
Ceska Slov Farm; 2016; 65(4):139-160. PubMed ID: 27860473
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of North American ginseng extract in the treatment of pediatric upper respiratory tract infection: a phase II randomized, controlled trial of 2 dosing schedules.
Vohra S; Johnston BC; Laycock KL; Midodzi WK; Dhunnoo I; Harris E; Baydala L
Pediatrics; 2008 Aug; 122(2):e402-10. PubMed ID: 18676527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
